Biotech innovations often get lost in translation between the lab, the investor deck, and the market. Icovy helps early-stage founders and growth-phase teams build investor-ready brands, regulatory-aligned messaging, and cross-functional strategies that bridge the gap between science and adoption.
We position your company to scale from molecule to market, unifying brand, content, and go-to-market systems into one cohesive growth engine.
Founders & Scientific Affairs leads preparing for funding rounds
Investor Relations & Communications teams seeking alignment
Translational & Clinical Development teams shaping product narratives
Commercial leads building GTM around regulatory and trial milestones
Boards and VC firms seeking portfolio acceleration
We develop decks, narrative architecture, and visual stories tied to funding strategy.
Build a repeatable system for blog, webinar, social, and partner education content.
We translate complex mechanisms of action into accessible, high-impact visuals.
Clarify your voice, positioning, and digital experience for investor and market credibility.
We help scientific founders become visible, strategic storytellers in the market.
Trusted by emerging biotech teams in therapeutics, diagnostics, AI drug discovery, and delivery platforms.
Helped preclinical startup raise Series A within 4 months of deck relaunch
Visual brand reposition led to 3 new strategic partner meetings in 60 days
Scientific content series increased trial awareness by 230%
Connect the dots between breakthrough science and commercial traction.